Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive HIV-1 and Hepatitis B Co-Infected Adults

  • STATUS
    Recruiting
  • End date
    Mar 28, 2024
  • participants needed
    240
  • sponsor
    Gilead Sciences
Updated on 6 June 2021

Summary

The primary objective of this study is to evaluate the efficacy of fixed-dose combination (FDC) of bictegravir/emtricitabine/ tenofovir alafenamide (B/F/TAF) versus dolutegravir (DTG) + emtricitabine/tenofovir disoproxil fumarate (F/TDF) in HIV and hepatitis B virus (HBV) treatment naive, HIV-1 and HBV co-infected adults.

Details
Condition HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection, HIV-1/HBV Co-Infection
Treatment B/F/TAF, DTG, Placebo to match DTG, Placebo to match F/TDF, F/TDF, Placebo to match B/F/TAF
Clinical Study IdentifierNCT03547908
SponsorGilead Sciences
Last Modified on6 June 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note